1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Registry marked status Unknown (sponsor has not verified the record since Sep 2023); last known: Recruiting
First Hospital of China Medical UniversityNot applicable NCT06059560 Registry history of NCT06059560 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-23 | NCT07835438 Transdermal Versus Intralesional Betamethasone for Keloids | Active, Not Recruiting |
| Phase 1/2 | 1 | |
| Phase 2 | 3 | |
| Phase 3 | 1 | |
| Phase 4 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07503652 | Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar… | Palmoplantar Pustulosis (PPP) | Recruiting | 2026-03-31 |
| NCT06508671 | Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment | Chemotherapy-Related Cognitive Impairment | Not Yet Recruiting | 2024-07-18 |
| Phase 3 | ||||
| NCT07476898 | Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion… | Stroke | Not Yet Recruiting | 2026-03-17 |
| Phase 2 | ||||
| NCT07483359 | Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular… | Hepatocellular Carcinoma (HCC) | Recruiting | 2026-05-28 |
| NCT07305246 | Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for… | Breast Cancer | Not Yet Recruiting | 2025-12-26 |
| NCT07271992 | TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab… | TNBC, Triple Negative Breast Cancer | Not Yet Recruiting | 2025-12-09 |
| Phase 1/2 | ||||
| NCT07059832 | Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography… | Cancer | Active, Not Recruiting | 2025-07-11 |
| Not applicable | ||||
| NCT06300138 | Antifungal Agents and Infrared Thermotherapy Alone or in Combination in the Treatment of… | Sporotrichosis | Recruiting | 2026-09-03 |
| NCT06812065 | Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the… | Warts | Recruiting | 2026-09-02 |
| NCT07565350 | Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts | Refactory Warts | Recruiting | 2026-05-04 |
| NCT07534865 | Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts | Warts | Recruiting | 2026-04-16 |
| NCT06827938 | Multicenter Real-World Study of Hyperthermia in Warts of Special Population | Warts | Recruiting | 2025-08-14 |
| NCT06637215 | Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer | Colorectal Carcinoma | Recruiting | 2024-11-27 |
| NCT07835438 | Transdermal Versus Intralesional Betamethasone for Keloids | Keloid | Active, Not Recruiting | 2026-09-23 |
| NCT07350486 | LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and… | Hypertension | Active, Not Recruiting | 2026-09-04 |
| NCT07059819 | Local Hyperthermia for the Treatment of Cervical Persistent High-risk Infection | Cervical Intraepithelial Neoplasia (CIN) | Enrolling by Invitation | 2026-09-02 |
| NCT03527719 | China Rural Hypertension Control Project | Hypertension | Active, Not Recruiting | 2025-12-18 |
| Not specified | ||||
| NCT07593209 | First-in-Human Study of the Radioligand 68Ga- DOTA-EphA2 | Malignant Tumor | Recruiting | 2026-05-18 |
| NCT07133516 | A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of… | Artificial Intelligence (AI) | Recruiting | 2025-08-21 |
| NCT07085650 | The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation and Recurrent… | Atrial Fibrillation (AF) | Recruiting | 2025-07-25 |
| NCT07040306 | A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China | Graves´ Disease | Recruiting | 2025-07-09 |
| NCT06696417 | Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis | Moderate to Severe Plaque Psoriasis | Recruiting | 2025-05-14 |
| NCT06632093 | HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC… | BCLC Stage B Hepatocellular Carcinoma | Recruiting | 2024-10-08 |
| NCT06282796 | Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer… | Breast Cancer | Recruiting | 2024-02-28 |
| NCT07319065 | Left Ventricular Myocardial Work for Predicting Response to CRT | CRT Non-Response | Not Yet Recruiting | 2026-01-06 |
Heart Disease (5) · Dementia (4) · Alzheimer's Disease (3) · Breast Cancer (3) · Hypertension (3) · Liver Cancer (3) · Heart Failure (2) · Psoriasis (2) · Stroke (2) · Atrial Fibrillation (1)